Publications by authors named "Arne Claeys"

Claim this Profile
S
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions.
Joachim T Siaw, Peter Merseburger, Marcus Borenäs, Caroline Jansson, Jenny Karlsson, Arne Claeys

J Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma.
Arne Claeys, Jimmy Van den Eynden

Commun Med (Lond)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer.
Jesse Demuytere, Charlotte Carlier, Tom Van Helden, Joke Belza, Frank Vanhaecke, Arne Claeys

Br J Surg· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN.
Jonatan L Gabre, Peter Merseburger, Arne Claeys, Joachim Siaw, Sarah-Lee Bekaert

NAR Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data.
Arne Claeys, Peter Merseburger, Jasper Staut, Kathleen Marchal, Jimmy Van den Eynden

BMC Genomics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-Letter.
Arne Claeys, Jimmy Van den Eynden

Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues.
Tom Luijts, Kerryn Elliott, Joachim Tetteh Siaw, Joris Van de Velde, Elien Beyls, Arne Claeys

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models.
Joanna Szydzik, Dan E Lind, Badrul Arefin, Yeshwant Kurhe, Ganesh Umapathy, Arne Claeys

Nat Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Marcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, Dan E Lind, Barbara Witek, Arne Claeys

EMBO J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signals.
Arne Claeys, Tom Luijts, Kathleen Marchal, Jimmy Van den Eynden

PLoS Genet· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis